NANOMICELLAR DISPERSION-BASED APPROACH TO IMPROVE AMISULPRIDE DISSOLUTION: FORMULATION, CHARACTERIZATION, AND IN VITRO RELEASE STUDY
DOI:
https://doi.org/10.22159/ijap.2025v17i5.55349Keywords:
Amisulpride, Nano micelle, In vitro release, Entrapment efficiency %Abstract
Objective: This research aims to overcome the solubility and absorption limitations of amisulpride (AMS) by formulating it into a nano-micellar (NM) delivery system, thereby improving its oral bioavailability and efficacy as an antiemetic through enhanced dissolution rate and extent.
Methods: Six types of nanocarriers, Soluplus(SLP), D-α-tocopheryl polyethylene glycol 1000 succinate(TGPS), Poloxamer (POL 188 and407), Solutol HS-15(STL-H15), and Tween-80, were used for the preparation of AMS as nano micellar dispersion(AMS-NM) either alone with 1:2,1:4,1:6, and 1:8 ratios or in combination with 1:4:1 and 1:4:2 ratios by utilizing Thin film hydration method. Twenty-four formulas were prepared and primarily checked for physical stability, then subjected to particle size (P. size), polydispersity index (PDI), entrapment efficiency (EE%), drug loading (DL%), and solubility factor (Sf) measurements. Only the selected formulas with accepted results of physical appearance and in vitro Characterization will progress to the release Study. Morphological and compatibility analyses, as well as Differential Scanning Calorimetry (DSC) and X-ray diffraction, were performed only for one optimal formula.
Results: Out of 24 nanomicelle formulations (F1–F24), four (F2, F4, F6, and F18) exhibited physical stability with optimal P. size, PDI, EE%, and Sf, qualifying them for further release studies. The formulation F2, containing a 1:4 ratio of SLP, emerged as the optimized system, achieving a complete (100%) release of AMS within 45 min, significantly surpassing the 24% release observed from the pure drug suspension. F2 demonstrated a nanoscale p. size of 67.1±2.2 nm, low PDI (0.061±0.002), high EE% (73±3.6), drug loading of 14.6±0.09%, and a solubility factor of 4.3. It presented a clear, faint light blue appearance with nano-spherical morphology, excellent drug-excipient compatibility, and structural stability. DSC and PXRD analyses confirmed successful AMS entrapment within the micellar core.
Conclusion: This strategy not only addresses AMS’s inherent solubility limitations but also utilizes nanoscale carrier properties and size-dependent mechanisms to enhance drug dissolution and absorption, thereby optimizing therapeutic delivery and showing great promise for improving clinical efficacy.
References
1. Alobaidy RA, Rajab NA. Preparation and in vitro evaluation of darifenacin HBr as nanoparticles prepared as nanosuspension. Iraqi J Pharm Sci. 2022;12(2):1-7. doi: 10.25258/ijddt.12.2.00.
2. Abdulqader AA, Rajab NA. Bioavailability study of posaconazole in rats after oral poloxamer p188 nano-micelles and oral posaconazole pure drug. J Adv Pharm Educ Res. 2023;13(2):140-3. doi: 10.51847/Q59uyvRmY3.
3. Piazzini V, D Ambrosio M, Luceri C, Cinci L, Landucci E, Bilia AR. Formulation of nanomicelles to improve the solubility and the oral absorption of silymarin. Molecules. 2019;24(9):1688. doi: 10.3390/molecules24091688, PMID 31052197.
4. Lu Y, Park K. Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs. Int J Pharm. 2013;453(1):198-214. doi: 10.1016/j.ijpharm.2012.08.042, PMID 22944304.
5. Pepic I, Lovric J, Filipovic Grcic J. How do polymeric micelles cross epithelial barriers? Eur J Pharm Sci. 2013;50(1):42-55. doi: 10.1016/j.ejps.2013.04.012, PMID 23619286.
6. Shakeri A, Sahebkar A. Opinion paper: nanotechnology: a successful approach to improve oral bioavailability of phytochemicals. Recent Pat Drug Deliv Formul. 2016;10(1):4-6. doi: 10.2174/1872211309666150611120724, PMID 26063398.
7. Center for Biotechnology. Information. PubChem compound summary for CID 2159. Amisulpride; 2025.
8. Herrstedt J, Summers Y, Jordan K, Von Pawel J, Jakobsen AH, Ewertz M. Amisulpride prevents nausea and vomiting associated with highly emetogenic chemotherapy: a randomised double-blind placebo-controlled dose-ranging trial. Support Care Cancer. 2019;27(7):2699-705. doi: 10.1007/s00520-018-4564-8, PMID 30488222.
9. Kang C, Shirley M. Amisulpride: a review in post-operative nausea and vomiting. Drugs. 2021;81(3):367-75. doi: 10.1007/s40265-020-01462-1, PMID 33656662.
10. Guembe Michel N, Nguewa P, Gonzalez Gaitano G. Soluplus®-based pharmaceutical formulations: recent advances in drug delivery and biomedical applications. Int J Mol Sci. 2025;26(4):1499. doi: 10.3390/ijms26041499, PMID 40003966.
11. Sparshatt A, Taylor D, Patel MX, Kapur S. Amisulpride dose plasma concentration occupancy and response: implications for therapeutic drug monitoring. Acta Psychiatr Scand. 2009;120(6):416-28. doi: 10.1111/j.1600-0447.2009.01429.x, PMID 19573049.
12. Musenga A, Mandrioli R, Morganti E, Fanali S, Raggi MA. Enantioselective analysis of amisulpride in pharmaceutical formulations by means of capillary electrophoresis. J Pharm Biomed Anal. 2008;46(5):966-70. doi: 10.1016/j.jpba.2007.05.022, PMID 17606354.
13. Schmitt U, Hiemke C, Hirtter S. P-glycoprotein (P-gp) affects the pharmacodynamics and of the atypical antipsychotic amisulpride. Pharmacopsychiatry. 2003;36(5):260. doi: 10.1055/s-2003-825503.
14. Singh S, Negi JS, Bisht R, Negi V, Kasliwal N, Thakur V. Development and evaluation of orodispersible sustained release formulation of amisulpride–γ-cyclodextrin inclusion complex. J Incl Phenom Macrocycl Chem. 2014;78(1-4):239-47. doi: 10.1007/s10847-013-0292-3.
15. Shi NQ, Lai HW, Zhang Y, Feng B, Xiao X, Zhang HM. On the inherent properties of soluplus and its application in ibuprofen solid dispersions generated by microwave quench cooling technology. Pharm Dev Technol. 2018;23(6):573-86. doi: 10.1080/10837450.2016.1256409, PMID 27824281.
16. Dian L, Yu E, Chen X, Wen X, Zhang Z, Qin L. Enhancing oral bioavailability of quercetin using novel soluplus polymeric micelles. Nanoscale Res Lett. 2014;9(1):2406. doi: 10.1186/1556-276X-9-684, PMID 26088982.
17. Pignatello R, Corsaro R, Bonaccorso A, Zingale E, Carbone C, Musumeci T. Soluplus® polymeric nanomicelles improve solubility of BCS-class II drugs. Drug Deliv Transl Res. 2022;12(8):1991-2006. doi: 10.1007/s13346-022-01182-x, PMID 35604634.
18. Mali KD, Shinde DT, Patil KR. Review on soluplus®: pharmaceuticals revolutionizing drug delivery and formulation strategies. Int J Pharm Investigation. 2025;15(2):344-60. doi: 10.5530/ijpi.20250146.
19. Alani AW, Rao DA, Seidel R, Wang J, Jiao J, Kwon GS. The effect of novel surfactants and solutol HS 15 on paclitaxel aqueous solubility and permeability across a caco-2 monolayer. J Pharm Sci. 2010;99(8):3473-85. doi: 10.1002/jps.22111, PMID 20198687.
20. Bergonzi MC, Vasarri M, Marroncini G, Barletta E, Degl Innocenti D. Thymoquinone-loaded soluplus®-solutol® HS15 mixed micelles: preparation in vitro characterization and effect on the SH-SY5Y cell migration. Molecules. 2020;25(20):4707. doi: 10.3390/molecules25204707, PMID 33066549.
21. Alzalzalee R, Kassab H. Factors affecting the preparation of cilnidipine nanoparticles. IJPS. 2023;32Suppl:235-43. doi: 10.31351/vol32issSuppl.pp235-243.
22. Salimi A, Sharif Makhmal Zadeh B, Kazemi M. Preparation and optimization of polymeric micelles as an oral drug delivery system for deferoxamine mesylate: in vitro and ex vivo studies. Res Pharm Sci. 2019;14(4):293-307. doi: 10.4103/1735-5362.263554, PMID 31516506.
23. Kontogiannis O, Selianitis D, Perinelli DR, Bonacucina G, Pippa N, Gazouli M. Non-ionic surfactant effects on innate pluronic 188 behavior: interactions and physicochemical and biocompatibility studies. Int J Mol Sci. 2022;23(22):13814. doi: 10.3390/ijms232213814, PMID 36430294.
24. Al Wiswasi N, Fatima J, Al Gawahri. Brimonidine soluplus nanomicelles: preparation and in vitro evaluation. Iraqi J Pharm Sci. 2025;34(1):246-55. doi: 10.31351/vol34iss1pp246-255.
25. Rajab NA, Jawad MS. Preparation and evaluation of rizatriptan benzoate loaded nanostructured lipid carrier using diff erent surfactant/co-surfactant systems. Int J Drug Deliv Technol. 2023;13(1):120-6. doi: 10.25258/ijddt.13.1.18.
26. Nizar Awish Jassem, Shaimaa Nazar Abd Alhammid. Formulation and evaluation of canagliflozin self-nanomicellizing solid dispersion based on rebaudioside a for dissolution and solubility improvement. Iraqi J Pharm Sci. 2025;33(4SI):43-56. doi: 10.31351/vol33iss(4SI)pp43-56.
27. Abed HN, Hussein AA. Ex-vivo absorption study of a novel dabigatran etexilate-loaded nanostructured lipid carrier using non-everted intestinal sac model. Iraqi J Pharm Sci. 2019;28(2):37-45. doi: 10.31351/vol28iss2pp37-45.
28. Hekmat A, Attar H, Seyf Kordi AA, Iman M, Jaafari MR. New oral formulation and in vitro evaluation of docetaxel-loaded nanomicelles. Molecules. 2016;21(9):1265. doi: 10.3390/molecules21091265, PMID 27657038.
29. Wang J, LV F, Sun T, Zhao S, Chen H, Liu Y. Sorafenib nanomicelles effectively shrink tumors by vaginal administration for preoperative chemotherapy of cervical cancer. Nanomaterials (Basel). 2021;11(12):3271. doi: 10.3390/nano11123271, PMID 34947619.
30. Rupp C, Steckel H, Muller BW. Solubilization of poorly water soluble drugs by mixed micelles based on hydrogenated phosphatidylcholine. Int J Pharm. 2010;395(1-2):272-80. doi: 10.1016/j.ijpharm.2010.05.025, PMID 20580793.
31. Bansal KK, Ali AA, Rahman M, Sjoholm E, Wilen CE, Rosenholm JM. Evaluation of solubilizing potential of functional poly(jasmine lactone) micelles for hydrophobic drugs: a comparison with commercially available polymers. Int J Polym Mater Polym Biomater. 2023;72(16):1272-80. doi: 10.1080/00914037.2022.2090942.
32. Kakad SP, Bharati YR, Kshirsagar SJ, Dashputre N, Tajanpure A, Kankate RS. Fabrication of amisulpride nanosuspension for nose-to-brain delivery in the potential antipsychotic treatment. Biosci Biotech Res Asia. 2024;21(1):109-21. doi: 10.13005/bbra/3207.
33. Tamer MA. The development of a brain-targeted mucoadhesive amisulpride-loaded nanostructured lipid carrier. Farmacia. 2023;71(5):1032-44. doi: 10.31925/farmacia.2023.5.18.
34. Mallappa DP, Chelsea FR, Ratnakar RP, Panchakshari GA, Shivamurthi MV, Uppinangady BS. Development and characterization of mucoadhesive buccal gel containing lipid nanoparticles of triamcinolone acetonide. Indian J Pharm Educ Res. 2020;54(3s):s505-11. doi: 10.5530/ijper.54.3s.149.
35. Lu P, Liang Z, Zhang Z, Yang J, Song F, Zhou T. Novel nanomicelle butenafine formulation for ocular drug delivery against fungal keratitis: in vitro and in vivo study. Eur J Pharm Sci. 2024;192:106629. doi: 10.1016/j.ejps.2023.106629, PMID 37918544.
36. Dou J, Zhang H, Liu X, Zhang M, Zhai G. Preparation and evaluation in vitro and in vivo of docetaxel-loaded mixed micelles for oral administration. Colloids Surf B Biointerfaces. 2014 Feb 1;114:20-7. doi: 10.1016/j.colsurfb.2013.09.010, PMID 24157590.
37. Jaber SH. Lasmiditan nanoemulsion-based in situ gel intranasal dosage form: formulation characterization and in vivo. Farmacia. 2023;71(6):1241-53. doi: 10.31925/farmacia.2023.6.15.
38. Dey NS, Mukherjee B, Maji R, Satapathy BS. Development of linker-conjugated nanosize lipid vesicles: a strategy for cell selective treatment in breast cancer. Curr Cancer Drug Targets. 2016;16(4):357-72. doi: 10.2174/1568009616666151106120606, PMID 26548758.
39. Akhtar MS, Mandal SK, Malik A, Choudhary A, Agarwal S, Sarkar S. Nano micelle: novel approach for targeted ocular drug delivery system. Egypt J Chem. 2022;65(12):337-55. doi: 10.21608/ejchem.2022.119133.5359.
40. Puppala RK, A VL. Optimization and solubilization study of nanoemulsion budesonide and constructing pseudoternary phase diagram. Asian J Pharm Clin Res. 2019;12(1):551. doi: 10.22159/ajpcr.2019.v12i1.28686.
41. Sulaiman HT. Soluplus and solutol hs-15 olmesartan medoxomil nanomicelle-based oral fast-dissolving film: in vitro and in vivo characterization. Farmacia. 2024;72(4):794-804. doi: 10.31925/farmacia.2024.4.7.
42. Pignatello R, Corsaro R, Bonaccorso A, Zingale E, Carbone C, Musumeci T. Soluplus® polymeric nanomicelles improve solubility of BCS-class II drugs. Drug Deliv Transl Res. 2022;12(8):1991-2006. doi: 10.1007/s13346-022-01182-x, PMID 35604634.
43. Jassem NA, Alhammid SN. Ex vivo permeability study and in vitro solubility characterization of oral canagliflozin self-nanomicellizing solid dispersion using soluplus ® as a nanocarrier. Acta Marisiensis Seria Medica. 2024;70(2):42-9. doi: 10.2478/amma-2024-0011.
44. Halah Talal Sulaiman, Nawal A, Rajab. Preparation and characterization of olmesartan medoxomil-loaded polymeric mixed micelle nanocarrier. Iraqi J Pharm Sci. 2025;33(4SI):89-100. doi: 10.31351/vol33iss(4SI)pp89-100.
45. Wu MY, Kao IF, Fu CY, Yen SK. Effects of adding chitosan on drug entrapment efficiency and release duration for paclitaxel-loaded hydroxyapatite gelatin composite microspheres. Pharmaceutics. 2023;15(8):2025. doi: 10.3390/pharmaceutics15082025, PMID 37631239.
46. Li S, Liu X, Liang X, Wang X. Dual reduction-sensitive nanomicelles for antitumor drug delivery with low toxicity to normal cells. ACS Appl Nano Mater. 2024;7(17):19952-62. doi: 10.1021/acsanm.4c01908.
47. Ghosh I, Schenck D, Bose S, Ruegger C. Optimization of formulation and process parameters for the production of nanosuspension by wet media milling technique: effect of vitamin E TPGS and nanocrystal particle size on oral absorption. Eur J Pharm Sci. 2012;47(4):718-28. doi: 10.1016/j.ejps.2012.08.011, PMID 22940548.
48. Ahmed TA, El Say KM, Ahmed OA, Aljaeid BM. Superiority of TPGS-loaded micelles in the brain delivery of vinpocetine via administration of thermosensitive intranasal gel. Int J Nanomedicine. 2019;14:5555-67. doi: 10.2147/IJN.S213086, PMID 31413562.
49. Mod Razif MR, Chan SY, Widodo RT, Chew YL, Hassan M, Hisham SA. Optimization of a luteolin-loaded TPGS/poloxamer 407 nanomicelle: the effects of copolymers hydration temperature and duration and freezing temperature on encapsulation efficiency, particle size and solubility. Cancers. 2023;15(14):3741. doi: 10.3390/cancers15143741, PMID 37509402.
50. Szafraniec J, Antosik A, Knapik Kowalczuk J, Chmiel K, Kurek M, Gawlak K. The self-assembly phenomenon of poloxamers and its effect on the dissolution of a poorly soluble drug from solid dispersions obtained by solvent methods. Pharmaceutics. 2019;11(3):130. doi: 10.3390/pharmaceutics11030130, PMID 30893859.
51. Gerardos AM, Balafouti A, Pispas S. Mixed copolymer micelles for nanomedicine. Nanomanufacturing. 2023;3(2):233-47. doi: 10.3390/nanomanufacturing3020015.
52. Attia MS, Elshahat A, Hamdy A, Fathi AM, Emad Eldin M, Ghazy FE. Soluplus® as a solubilizing excipient for poorly water-soluble drugs: recent advances in formulation strategies and pharmaceutical product features. J Drug Deliv Sci Technol. 2023 Jun;84:104519. doi: 10.1016/j.jddst.2023.104519.
53. Yassin AE, Massadeh S, Alshwaimi AA, Kittaneh RH, Omer ME, Ahmad D. Tween 80-based self-assembled mixed micelles boost valsartan transdermal delivery. Pharmaceuticals (Basel). 2023;17(1):19. doi: 10.3390/ph17010019, PMID 38256853.
54. Ding Y, Ding Y, Wang Y, Wang C, Gao M, Xu Y. Soluplus®/TPGS mixed micelles for co-delivery of docetaxel and piperine for combination cancer therapy. Pharm Dev Technol. 2020;25(1):107-15. doi: 10.1080/10837450.2019.1679834, PMID 31603017.
55. Woodhead JL, Hall CK. Encapsulation efficiency and micellar structure of solute-carrying block copolymer nanoparticles. Macromolecules. 2011;44(13):5443-51. doi: 10.1021/ma102938g, PMID 21918582.
56. Bernabeu E, Gonzalez L, Cagel M, Moretton MA, Chiappetta DA. Deoxycholate-TPGS mixed nanomicelles for encapsulation of methotrexate with enhanced in vitro cytotoxicity on breast cancer cell lines. J Drug Deliv Sci Technol. 2019;50:293-304. doi: 10.1016/j.jddst.2019.01.041.
57. Muhannad Salah, Luay Radhi, Mohammed Al Lami. Preparation and characterization of diazepam-loaded nanomicelles for pediatric intravenous dose adjustment. IJPR. 2020;13(1):2275-86. doi: 10.31838/ijpr/2021.13.01.361.
58. Li X, Zhang Y, Fan Y, Zhou Y, Wang X, Fan C. Preparation and evaluation of novel mixed micelles as nanocarriers for intravenous delivery of propofol. Nanoscale Res Lett. 2011;6(1):275. doi: 10.1186/1556-276X-6-275, PMID 21711808.
59. Gohar S, Iqbal Z, Nasir F, Khattak MA, E Maryam G, Pervez S. Self-assembled latanoprost-loaded soluplus nanomicelles as an ophthalmic drug delivery system for the management of glaucoma. Sci Rep. 2024;14(1):27051. doi: 10.1038/s41598-024-78244-2, PMID 39511270.
60. Kaur M, Rathee A, Krishna V, Nagpal M. Soluplus-based polymeric micelles: a promising carrier system for challenging drugs. Int J Pharm Sci Rev Res. 2024;84(9):83-93. doi: 10.47583/ijpsrr.2024.v84i09.014.
61. Saba Abdulhadi Jaber, Nawal Ayash Rajab. Preparation and in vitro/ex vivo evaluation of nanoemulsion-based in situ gel for intranasal delivery of lasmiditan. IJPS. 2024;33(3):128-41. doi: 10.31351/vol33iss3pp128-141.
62. Tamer MA, Kassab HJ. Optimizing intranasal amisulpride loaded nanostructured lipid carriers: formulation development and characterization parameters. Pharm Nanotechnol. 2025;13(2):287-302. doi: 10.2174/0122117385301604240226111533, PMID 40007188.
63. Sukamporn P, Baek SJ, Gritsanapan W, Chirachanchai S, Nualsanit T, Rojanapanthu P. Self-assembled nanomicelles of damnacanthal loaded amphiphilic modified chitosan: preparation, characterization and cytotoxicity study. Mater Sci Eng C Mater Biol Appl. 2017 Aug 1;77:1068-77. doi: 10.1016/j.msec.2017.03.263, PMID 28531980.
64. Rathee A, Solanki P, Emad NA, Zai I, Ahmad S, Alam S. Posaconazole-hemp seed oil loaded nanomicelles for invasive fungal disease. Sci Rep. 2024;14(1):16588. doi: 10.1038/s41598-024-66074-1, PMID 39025925.
65. Dino SF, Edu AD, Francisco RG, Gutierrez E, Crucis P, Lapuz AM. Drug excipient compatibility testing of cilostazol using FTIR and DSC analysis. Philipp J Sci. 2023;152(6A):2129-37. doi: 10.56899/152.6A.08.
Published
How to Cite
Issue
Section
Copyright (c) 2025 HAIDER HANI HASHIM, SABA ABDULHADI JABER
This work is licensed under a Creative Commons Attribution 4.0 International License.
